Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inovio Pharma (INO)

Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 110,772
  • Shares Outstanding, K 66,730
  • Annual Sales, $ 220 K
  • Annual Income, $ -107,250 K
  • EBIT $ -96 M
  • EBITDA $ -93 M
  • 60-Month Beta 1.70
  • Price/Sales 1,704.18
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 157.84% (-34.51%)
  • Historical Volatility 48.21%
  • IV Percentile 28%
  • IV Rank 10.92%
  • IV High 908.26% on 08/07/25
  • IV Low 65.86% on 05/05/25
  • Expected Move (DTE 5) 0.3230 (19.46%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 833
  • Volume Avg (30-Day) 511
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 24,135
  • Open Int (30-Day) 25,347
  • Expected Range 1.3370 to 1.9830

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -0.34
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5600 +6.41%
on 02/17/26
2.0300 -18.23%
on 02/24/26
+0.0500 (+3.11%)
since 02/13/26
3-Month
1.4700 +12.93%
on 01/20/26
2.7200 -38.97%
on 12/17/25
-0.4000 (-19.42%)
since 12/12/25
52-Week
1.3000 +27.69%
on 07/15/25
2.9789 -44.27%
on 09/09/25
-0.2700 (-13.99%)
since 03/13/25

Most Recent Stories

More News
Inovio: Q4 Earnings Snapshot

Inovio: Q4 Earnings Snapshot

INO : 1.6600 (-1.19%)
Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , March 12, 2026 /PRNewswire/ --  The Law Offices of Frank R. Cruz announces that investors with losses related to Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:...

INO : 1.6600 (-1.19%)
INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

PLYMOUTH MEETING, Pa. , March 12, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 1.6600 (-1.19%)
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO

NEW YORK , March 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO) and certain...

INO : 1.6600 (-1.19%)
Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , March 11, 2026 /PRNewswire/ --  The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud ...

INO : 1.6600 (-1.19%)
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options

INO : 1.6600 (-1.19%)
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO

NEW YORK , March 10, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of  Inovio Pharmaceuticals, Inc. (NASDAQ: INO).

INO : 1.6600 (-1.19%)
INOVIO to Participate in Upcoming Scientific Conferences

PLYMOUTH MEETING, Pa. , March 9, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated...

INO : 1.6600 (-1.19%)
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options

INO : 1.6600 (-1.19%)
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO

NEW YORK , March 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO) and certain...

INO : 1.6600 (-1.19%)

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 1.8567
2nd Resistance Point 1.8133
1st Resistance Point 1.7367
Last Price 1.6600
1st Support Level 1.6167
2nd Support Level 1.5733
3rd Support Level 1.4967

See More

52-Week High 2.9789
Fibonacci 61.8% 2.3376
Fibonacci 50% 2.1395
Fibonacci 38.2% 1.9413
Last Price 1.6600
52-Week Low 1.3000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar